Global Topical Pain Relief Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

The global topical pain relief market size reached US$ 9.9 Billion in 2022. Looking forward, the market is expected to reach US$ 14.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.20% during 2022-2028.

Topical preparations for pain relief are generally available in the form of liquids, gels, powders, creams, semisolids, emulsions, patches, foams, or aerosols. They are applied on or around the site of pain or inflammation in case of strains, sprains, tendinopathy, muscle aches, and osteoarthritis. They gradually enter the bloodstream and keep the blood levels relatively constant for a certain period. At present, pharmaceutical companies around the world are focusing on developing new routes of drug administration for providing personalized treatments to patients without decreasing the efficacy of topical analgesic or pain-relieving drugs.

Topical Pain Relief Market Trends

The increasing prevalence of chronic pain on account of diabetic neuropathy, arthritis, multiple sclerosis, fibromyalgia, and shingles represents one of the significant factors escalating the demand for topical pain relief medications across the globe. Apart from this, the rising number of individuals participating in sports activities is also positively influencing the sales of topical pain relief medications worldwide. Moreover, the growing number of cancer patients is resulting in the increasing sales of topical pain relievers via e-commerce platforms. Furthermore, leading pharmaceutical companies are introducing topical painkillers or analgesics for managing the pain of cancer patients. They are also focusing on the development of medications that simplify treatment and reduce adverse effects. This is anticipated to expand the applications of topical pain relief medications amongst elderly and pediatric populations, as well as individuals who are intolerant to other routes of administration.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global topical pain relief market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on therapeutic class, formulation, type and distribution channel.

Breakup by Therapeutic Class:

• Non-Opioids
• Opioids

Breakup by Formulation:

• Cream
• Gel
• Spray
• Patch

Breakup by Type:

• Prescription Pain Relief
• Over the Counter (OTC) Pain Relief

Breakup by Distribution Channel:

• Pharmacy and Drug Stores
• Retail Stores
• Online Stores

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Latin America
• Brazil
• Mexico
• Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Advacare Pharma, Exzell Pharma Inc., Glaxosmithkline Plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi S.A., Sun Pharmaceutical Industries Limited and Topical Biomedics Inc.

Key Questions Answered in This Report:

• How has the global topical pain relief market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global topical pain relief market?
• What are the key regional markets?
• What is the breakup of the market based on the therapeutic class?
• What is the breakup of the market based on the formulation?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global topical pain relief market and who are the key players?
• What is the degree of competition in the industry?